VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
WATWaters Corporation
$355.44$23.2B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

WAT logoWaters Corporation(WAT)Earnings, Financials & Key Ratios

WAT•NYSE
33.0× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryLife Science Instruments and Sequencing Tools
AboutWaters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.Show more
  • Revenue$3.17B+7.0%
  • EBITDA$1.1B+8.0%
  • Net Income$643M+0.8%
  • EPS (Diluted)10.76+0.5%
  • Gross Margin57.77%-2.8%
  • EBITDA Margin34.73%+0.9%
  • Operating Margin28.22%+1.0%
  • Net Margin20.3%-5.8%
  • ROE29.28%-31.6%

WAT Key Insights

Waters Corporation (WAT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 49.9%
  • ✓FCF machine: 17.1% free cash flow margin
  • ✓Healthy 5Y average net margin of 22.5%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when WAT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

WAT Price & Volume

Waters Corporation (WAT) stock price & volume — 10-year historical chart

Loading chart...

WAT Growth Metrics

Waters Corporation (WAT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years4.48%
5 Years6%
3 Years2.12%
TTM26.39%

Profit CAGR

10 Years3.2%
5 Years4.26%
3 Years-3.17%
TTM-31.62%

EPS CAGR

10 Years6.65%
5 Years5.18%
3 Years-2.84%
TTM-28.58%

Return on Capital

10 Years24.72%
5 Years27.72%
3 Years22.03%
Last Year18.54%

WAT Recent Earnings

Waters Corporation (WAT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$2.70+16.9%
$2.31
Rev
$1.3B+5.3%
$1.2B
Q1 2026
Feb 9, 2026
Metric
Actual
Est
EPS
$4.53+0.4%
$4.51
Rev
$932M+0.4%
$928M
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$3.40+5.9%
$3.21
Rev
$800M+2.4%
$781M
Q3 2025
Aug 4, 2025
Metric
Actual
Est
EPS
$2.95+0.3%
$2.94
Rev
$771M+3.0%
$749M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$2.70vs $2.31+16.9%
$1.3Bvs $1.2B+5.3%
Q1 2026Feb 9, 2026
$4.53vs $4.51+0.4%
$932Mvs $928M+0.4%
Q4 2025Nov 4, 2025
$3.40vs $3.21+5.9%
$800Mvs $781M+2.4%
Q3 2025Aug 4, 2025
$2.95vs $2.94+0.3%
$771Mvs $749M+3.0%
Based on last 12 quarters of dataView full earnings history →

WAT Peer Comparison

Waters Corporation (WAT) competitors in Life Science Instruments and Sequencing Tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
A logoAAgilent Technologies, Inc.Direct Competitor35.89B127.0627.806.73%19.55%20.84%0.50
BRKR logoBRKRBruker CorporationDirect Competitor8.71B57.23-381.532.08%-0.34%-0.5%0.81
MTSI logoMTSIMACOM Technology Solutions Holdings, Inc.Direct Competitor29.86B391.41-536.1832.58%16.46%13.19%0.41
SHIM logoSHIMShimmick Corporation Common StockDirect Competitor134.31M3.66-4.952.63%-4.44%
TMO logoTMOThermo Fisher Scientific Inc.Product Competitor172.66B464.6126.193.91%15.18%13.23%0.76
DHR logoDHRDanaher CorporationProduct Competitor125.4B177.1735.152.9%14.89%7.06%0.35
RGEN logoRGENRepligen CorporationProduct Competitor7.45B132.02153.5116.36%6.73%2.46%0.33
AZTA logoAZTAAzenta, Inc.Product Competitor1.07B23.31-19.113.55%-29.86%-10.69%0.06

Compare WAT vs Peers

Waters Corporation (WAT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs A

Most directly comparable listed peer for WAT.

Scale Benchmark

vs TMO

Larger-name benchmark to compare WAT against a more recognizable public peer.

Peer Set

Compare Top 5

vs A, BRKR, MTSI, SHIM

WAT Income Statement

Waters Corporation (WAT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
2.31B2.42B2.41B2.37B2.79B2.97B2.96B2.96B3.17B3.77B
Revenue Growth %
6.54%4.8%-0.55%-1.71%17.78%6.68%-0.52%0.07%6.99%26.39%
Cost of Goods Sold
947.07M992.56M1.01B1.01B1.16B1.25B1.2B1.2B1.34B1.7B
COGS % of Revenue
41.01%41.02%42%42.56%41.51%42%40.43%40.57%42.23%-
Gross Profit
1.36B▲ 0%
1.43B▲ 4.8%
1.4B▼ 2.2%
1.36B▼ 2.7%
1.63B▲ 19.9%
1.72B▲ 5.8%
1.76B▲ 2.2%
1.76B▼ 0.2%
1.83B▲ 4.0%
2.07B▲ 0%
Gross Margin %
58.99%58.98%58%57.44%58.49%58%59.57%59.43%57.77%55.02%
Gross Profit Growth %
6.74%4.8%-2.2%-2.67%19.92%5.8%2.17%-0.17%4.01%-
Operating Expenses
699.81M687.59M687.44M713.19M807.63M850.38M943.52M931.83M935.45M1.43B
OpEx % of Revenue
30.31%28.41%28.56%30.15%28.99%28.61%31.91%31.5%29.55%-
Selling, General & Admin
544.36M536.9M534.79M553.7M626.97M658.03M736.01M690.15M740.27M1.01B
SG&A % of Revenue
23.57%22.19%22.22%23.41%22.51%22.14%24.9%23.33%23.39%-
Research & Development
132.59M143.4M142.96M140.78M168.36M176.19M174.94M183.03M195.18M248.29M
R&D % of Revenue
5.74%5.93%5.94%5.95%6.04%5.93%5.92%6.19%6.17%-
Other Operating Expenses
22.86M7.29M9.69M18.71M12.31M16.16M32.56M58.66M03M
Operating Income
662.2M▲ 0%
739.77M▲ 11.7%
708.46M▼ 4.2%
645.49M▼ 8.9%
821.71M▲ 27.3%
873.39M▲ 6.3%
817.68M▼ 6.4%
826.35M▲ 1.1%
893.22M▲ 8.1%
643.9M▲ 0%
Operating Margin %
28.68%30.57%29.44%27.29%29.5%29.39%27.66%27.93%28.22%17.08%
Operating Income Growth %
5.95%11.71%-4.23%-8.89%27.3%6.29%-6.38%1.06%8.09%-
EBITDA
768.2M848.18M813.75M770.85M953.39M1B983.58M1.02B1.1B952.77M
EBITDA Margin %
33.27%35.05%33.81%32.59%34.22%33.78%33.27%34.42%34.73%25.27%
EBITDA Growth %
6.47%10.41%-4.06%-5.27%23.68%5.29%-2.02%3.52%7.98%-8.12%
D&A (Non-Cash Add-back)
106M108.41M105.3M125.36M131.68M130.42M165.91M191.82M206.24M308.87M
EBIT
697.94M730.79M726.93M659.98M851.13M886.64M835.1M844.54M805.65M615.6M
Net Interest Income
-20.76M-9.83M-26.63M-32.8M-32.72M-37.78M-82.24M-72.26M-50.77M-82.39M
Interest Income
36.08M38.81M22.06M16.27M12.22M11.02M16.62M17.42M09.22M
Interest Expense
56.84M48.64M48.69M49.07M44.94M48.8M98.86M89.68M50.77M91.61M
Other Income/Expense
-21.1M-57.63M-30.22M-34.58M-15.51M-35.55M-81.43M-71.48M-138.34M-119.91M
Pretax Income
641.1M▲ 0%
682.15M▲ 6.4%
678.24M▼ 0.6%
610.91M▼ 9.9%
806.19M▲ 32.0%
837.85M▲ 3.9%
736.24M▼ 12.1%
754.87M▲ 2.5%
754.88M▲ 0.0%
523.99M▲ 0%
Pretax Margin %
27.76%28.19%28.18%25.83%28.94%28.19%24.9%25.52%23.85%13.9%
Income Tax
620.79M88.35M86.04M89.34M113.35M130.09M94.01M117.03M112.25M74.74M
Effective Tax Rate %
96.83%12.95%12.69%14.62%14.06%15.53%12.77%15.5%14.87%14.26%
Net Income
20.31M▲ 0%
593.79M▲ 2823.5%
592.2M▼ 0.3%
521.57M▼ 11.9%
692.84M▲ 32.8%
707.75M▲ 2.2%
642.23M▼ 9.3%
637.83M▼ 0.7%
642.63M▲ 0.8%
449.25M▲ 0%
Net Margin %
0.88%24.54%24.61%22.05%24.87%23.81%21.72%21.56%20.3%11.91%
Net Income Growth %
-96.11%2823.51%-0.27%-11.93%32.84%2.15%-9.26%-0.69%0.75%-31.62%
Net Income (Continuing)
20.31M593.79M592.2M521.57M692.84M707.75M642.23M637.83M642.63M449.25M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
0.25▲ 0%
7.65▲ 2960.0%
8.69▲ 13.6%
8.36▼ 3.8%
11.17▲ 33.6%
11.73▲ 5.0%
10.84▼ 7.6%
10.71▼ 1.2%
10.76▲ 0.5%
5.47▲ 0%
EPS Growth %
-96.1%2960%13.59%-3.8%33.61%5.01%-7.59%-1.2%0.47%-28.58%
EPS (Basic)
0.257.718.768.4011.2511.8010.8710.7510.80-
Diluted Shares Outstanding
80.6M77.62M68.17M62.41M62.03M60.33M59.27M59.55M59.71M82.14M
Basic Shares Outstanding
79.79M76.99M67.63M62.09M61.58M59.98M59.08M59.33M59.51M82.14M
Dividend Payout Ratio
----------

WAT Balance Sheet

Waters Corporation (WAT) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
4.27B2.66B1.31B1.4B1.63B1.76B1.75B1.67B1.99B3.72B
Cash & Short-Term Investments
3.39B1.74B337.14M443.15M569.28M481.39M395.97M325.36M587.83M462M
Cash Only
642.32M796.28M335.71M436.69M501.23M480.53M395.08M324.42M587.83M462M
Short-Term Investments
2.75B938.94M1.43M6.45M68.05M862K898K934K00
Accounts Receivable
533.83M568.32M587.73M573.32M612.65M722.89M702.17M733.37M828.84M1.76B
Days Sales Outstanding
84.3885.7289.1488.4780.2788.7886.6990.4895.5898.41
Inventory
270.29M291.57M320.55M304.28M356.1M455.71M516.24M477.26M572.37M1.5B
Days Inventory Outstanding
104.17107.22115.76110.32112.38133.26157.65145.14156.3171.19
Other Current Assets
72.31M68.05M67.06M80.29M90.91M103.91M138.49M133.13M00
Total Non-Current Assets
1.05B1.06B1.24B1.44B1.47B1.52B2.87B2.88B3.09B20.81B
Property, Plant & Equipment
349.28M343.08M510.7M587.25M632.65M668.72M723.66M725.39M642.05M1.52B
Fixed Asset Turnover
6.61x7.05x4.71x4.03x4.40x4.44x4.09x4.08x4.93x4.19x
Goodwill
359.82M355.61M356.13M444.36M437.87M430.33M1.31B1.3B1.34B9.32B
Intangible Assets
228.4M246.9M240.2M258.64M242.4M227.4M629.19M567.91M558.18M8.78B
Long-Term Investments
000000000346K
Other Non-Current Assets
116.73M118.66M137.53M148.63M153.08M191.1M215.69M295.67M554.62M1.2B
Total Assets
5.34B▲ 0%
3.73B▼ 30.2%
2.56B▼ 31.4%
2.84B▲ 11.1%
3.09B▲ 9.0%
3.28B▲ 6.0%
4.63B▲ 41.0%
4.55B▼ 1.6%
5.08B▲ 11.6%
24.53B▲ 0%
Asset Turnover
0.43x0.65x0.94x0.83x0.90x0.91x0.64x0.65x0.62x0.38x
Asset Growth %
14.53%-30.19%-31.4%11.06%8.98%6.03%41%-1.58%11.64%459.73%
Total Current Liabilities
606.16M448.93M591.33M804.98M680.51M785.74M789.58M789.76M00
Accounts Payable
64.54M68.17M49M72.21M96.8M93.3M84.7M99.93M00
Days Payables Outstanding
24.8725.0717.726.1830.5527.2825.8730.39-11.49
Short-Term Debt
100.27M178K100.37M150M050M50M000
Deferred Revenue (Current)
166.84M164.97M176.36M198.24M227.56M227.91M256.68M250.81M0635.19M
Other Current Liabilities
188.47M180.38M180.55M269.26M256.25M243.6M238.07M243.22M00
Current Ratio
7.04x5.93x2.22x1.74x2.39x2.24x2.22x2.11x--
Quick Ratio
6.60x5.28x1.68x1.36x1.87x1.66x1.57x1.51x--
Cash Conversion Cycle
163.68167.87187.21172.61162.1194.76218.47205.23-258.11
Total Non-Current Liabilities
2.48B1.71B2.18B1.8B2.05B1.99B2.69B1.94B2.52B9.24B
Long-Term Debt
1.9B1.15B1.58B1.21B1.51B1.52B2.31B1.63B1.41B5.21B
Capital Lease Obligations
0066.88M68.2M59.62M62.11M58.93M50.32M0103.13M
Deferred Tax Liabilities
00000000030.88M
Other Non-Current Liabilities
586.91M563.07M534.32M528.08M473.38M404.24M322.49M258.73M1.12B4.02B
Total Liabilities
3.11B2.16B2.77B2.61B2.73B2.78B3.48B2.73B2.52B9.24B
Total Debt
2B1.15B1.78B1.45B1.6B1.66B2.44B1.7B1.41B5.21B
Net Debt
1.36B352.07M1.44B1.02B1.1B1.18B2.05B1.38B819.61M4.75B
Debt / Equity
0.89x0.73x-6.26x4.36x3.30x2.12x0.93x0.55x0.34x
Debt / EBITDA
2.60x1.35x2.18x1.88x1.68x1.66x2.48x1.67x1.28x5.47x
Net Debt / EBITDA
1.76x0.42x1.77x1.32x1.15x1.18x2.08x1.35x0.75x4.99x
Interest Coverage
12.28x15.02x14.93x13.45x18.94x18.17x8.45x9.42x15.87x6.72x
Total Equity
2.23B▲ 0%
1.57B▼ 29.8%
-216.28M▼ 113.8%
232.14M▲ 207.3%
367.55M▲ 58.3%
504.49M▲ 37.3%
1.15B▲ 128.0%
1.83B▲ 59.0%
2.56B▲ 40.1%
15.29B▲ 0%
Equity Growth %
-2.96%-29.84%-113.8%207.33%58.33%37.26%128.02%58.95%40.07%817.68%
Book Value per Share
27.7120.19-3.173.725.938.3619.4130.7042.90186.17
Total Shareholders' Equity
2.23B1.57B-216.28M232.14M367.55M504.49M1.15B1.83B2.56B15.29B
Common Stock
1.6M1.6M1.61M1.62M1.62M1.62M1.63M1.63M2.56B0
Retained Earnings
5.41B6B6.59B7.11B7.8B8.51B9.15B9.79B00
Treasury Stock
-4.81B-6.15B-8.61B-8.79B-9.44B-10.06B-10.13B-10.15B00
Accumulated OCI
-110.07M-117.97M-119.47M-117.94M-111.86M-141.57M-134.12M-155.28M00
Minority Interest
0000000000

WAT Cash Flow Statement

Waters Corporation (WAT) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
697.64M604.45M643.09M790.51M747.27M611.66M602.81M762.12M652.55M390M
Operating CF Margin %
30.21%24.98%26.72%33.42%26.82%20.58%20.39%25.76%20.62%-
Operating CF Growth %
10.9%-13.36%6.39%22.92%-5.47%-18.15%-1.45%26.43%-14.38%-165.63%
Net Income
20.31M593.79M592.2M521.57M692.84M707.75M642.23M637.83M642.63M449.25M
Depreciation & Amortization
106M108.41M105.3M135.35M131.68M130.42M165.91M191.82M206.24M462.87M
Stock-Based Compensation
39.44M37.54M38.58M36.87M29.92M42.56M36.87M44.71M54.13M61.25M
Deferred Taxes
45.51M2.4M9.62M-2.69M16.63M-31.99M-1.2M-877K0-19.58M
Other Non-Cash Items
-45.51M-2.4M-9.62M2.69M-16.63M31.99M-742K00-88.19M
Working Capital Changes
531.89M-135.3M-92.98M96.72M-107.17M-269.08M-240.26M-111.37M-250.44M-475.6M
Change in Receivables
-24.01M-47.92M-22.2M37.47M-62.45M-137.87M49.18M-66.24M0-6.94M
Change in Inventory
731K-25.4M-31.85M18.94M-67.25M-101.9M-45.44M20.94M0-39.97M
Change in Payables
3.17M-81.66M9.78M140.6M46.11M60.98M-79.52M61.59M0-84.25M
Cash from Investing
-535.75M1.68B768.8M-264.09M-231.63M-107.97M-1.44B-144.02M-152.25M-31M
Capital Expenditures
-90.47M-127.56M-163.82M-172.38M-168.27M-183.46M-160.63M-142.48M-112.75M-126M
CapEx % of Revenue
3.92%5.27%6.81%7.29%6.04%6.17%5.43%4.82%3.56%3.34%
Acquisitions
-2.52B-31.49M8.84M-86.69M7M-1.37M-1.28B-1.49M-35.05M109.45M
Investments
----------
Other Investing
-7M31.49M-8.84M6.14M-225.08M1.37M002.84M2.33M
Cash from Financing
-63.87M-2.12B-1.87B-440.5M-438.27M-509.63M754.95M-696.67M-237.21M-276.96M
Debt Issued (Net)
169.98M-850.16M535.19M-325.37M160M60M780M-730M-243.32M-155.81M
Equity Issued (Net)
-332.54M-1.32B-2.47B-196.41M-648.93M-626.06M-70.28M-13.54M6.12M2.81M
Dividends Paid
0000000000
Share Repurchases
-332.54M-1.32B-2.47B-196.41M-648.93M-626.06M-70.28M-13.54M-14.67M-12.73M
Other Financing
98.7M45.74M61.39M81.27M50.66M56.43M45.23M46.87M-7K-123.96M
Net Change in Cash
136.69M▲ 0%
153.96M▲ 12.6%
-460.56M▼ 399.1%
100.98M▲ 121.9%
64.54M▼ 36.1%
-20.7M▼ 132.1%
-85.45M▼ 312.7%
-70.66M▲ 17.3%
262.48M▲ 471.5%
78.96M▲ 0%
Free Cash Flow
607.17M▲ 0%
476.88M▼ 21.5%
479.26M▲ 0.5%
618.12M▲ 29.0%
579.01M▼ 6.3%
428.2M▼ 26.0%
442.18M▲ 3.3%
619.64M▲ 40.1%
539.81M▼ 12.9%
264M▲ 0%
FCF Margin %
26.29%19.71%19.91%26.13%20.78%14.41%14.96%20.95%17.05%7%
FCF Growth %
13.68%-21.46%0.5%28.97%-6.33%-26.05%3.26%40.13%-12.88%-57.37%
FCF per Share
7.536.147.039.909.337.107.4610.419.043.21
FCF Conversion (FCF/Net Income)
34.35x1.02x1.09x1.52x1.08x0.86x0.94x1.19x1.02x0.59x
Interest Paid
56.5M50.8M42.84M52.1M42.41M48.08M94.1M92.1M00
Taxes Paid
70.58M159.4M88M97.62M153.5M160.08M243.32M183.34M00

WAT Key Ratios

Waters Corporation (WAT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
0.9%31.24%87.67%6575.94%231.06%162.32%77.62%42.82%29.28%8.04%
Return on Invested Capital (ROIC)
13.77%20.14%33.82%39.18%45.39%41.52%25.11%19.36%20.34%6.41%
Gross Margin
58.99%58.98%58%57.44%58.49%58%59.57%59.43%57.77%55.02%
Net Margin
0.88%24.54%24.61%22.05%24.87%23.81%21.72%21.56%20.3%11.91%
Debt / Equity
0.89x0.73x-6.26x4.36x3.30x2.12x0.93x0.55x0.34x
Interest Coverage
12.28x15.02x14.93x13.45x18.94x18.17x8.45x9.42x15.87x6.72x
FCF Conversion
34.35x1.02x1.09x1.52x1.08x0.86x0.94x1.19x1.02x0.59x
Revenue Growth
6.54%4.8%-0.55%-1.71%17.78%6.68%-0.52%0.07%6.99%26.39%
Related:WAT Dividend History·WAT Revenue History·WAT Price History·WAT P/E History·WAT Financial Ratios·WAT Institutional Holders

WAT SEC Filings & Documents

Waters Corporation (WAT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Mar 23, 2026·SEC

Material company update

Mar 16, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 23, 2026·SEC

FY 2025

Feb 25, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 4, 2025·SEC

FY 2025

May 6, 2025·SEC

WAT Frequently Asked Questions

Waters Corporation (WAT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Waters Corporation (WAT) reported $3.77B in revenue for fiscal year 2025. This represents a 864% increase from $391.1M in 1996.

Waters Corporation (WAT) grew revenue by 7.0% over the past year. This is steady growth.

Yes, Waters Corporation (WAT) is profitable, generating $449.2M in net income for fiscal year 2025 (20.3% net margin).

Dividend & Returns

Waters Corporation (WAT) has a return on equity (ROE) of 29.3%. This is excellent, indicating efficient use of shareholder capital.

Waters Corporation (WAT) generated $264.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in WAT back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in WAT be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →